...
首页> 外文期刊>Expert opinion on therapeutic targets >Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.
【24h】

Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.

机译:用青蒿素和青蒿素标记的载铁化合物靶向治疗癌症。

获取原文
获取原文并翻译 | 示例
           

摘要

Artemisinin is a chemical compound that reacts with iron to form free radicals which can kill cells. Cancer cells require and uptake a large amount of iron to proliferate. They are more susceptible to the cytotoxic effect of artemisinin than normal cells. Cancer cells express a large concentration of cell surface transferrin receptors that facilitate uptake of the plasma iron-carrying protein transferrin via endocytosis. By covalently tagging artemisinin to transferrin, artemisinin could be selectively picked up and concentrated by cancer cells. Futhermore, both artemisinin and iron would be transported into the cell in one package. Once an artemisinin-tagged transferrin molecule is endocytosed, iron is released and reacts with artemisinin moieties tagged to transferrin. Formation of free radicals kills the cancer cell. The authors have found that artemisinin-tagged transferrin is highly selective and potent in killing cancer cells. Thus, artemisinin and artemisinin-tagged iron-carrying compounds couldbe developed into powerful anticancer drugs.
机译:青蒿素是一种与铁反应形成自由基的化学化合物,可以杀死细胞。癌细胞需要并摄取大量的铁才能增殖。它们比普通细胞更容易受到青蒿素的细胞毒性作用。癌细胞表达高浓度的细胞表面转铁蛋白受体,这些受体促进通过内吞作用吸收血浆载铁蛋白转铁蛋白。通过将青蒿素共价标记到运铁蛋白上,青蒿素可以被癌细胞选择性地吸收和浓缩。此外,青蒿素和铁都将在一个包装中运输到细胞中。一旦青蒿素标记的运铁蛋白分子被内吞,铁就会释放出来并与标记有运铁蛋白的青蒿素部分反应。自由基的形成会杀死癌细胞。作者发现,青蒿素标记的转铁蛋白具有很高的选择性,并能有效杀死癌细胞。因此,青蒿素和青蒿素标记的载铁化合物可以发展成为强大的抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号